Market Overview

Benzinga's Top Downgrades

Related ENDP
Pacira's Exparel Positive In Phase IV Studies - Analyst Blog
Endo International to Expand Generics Business with DAVA Buy - Analyst Blog
Related FHN
First Horizon's Cost Containment Continues - Analyst Blog
First Horizon to Expand Tennessee Network - Analyst Blog

Analysts at Cantor Fitzgerald downgraded Endo Health Solutions (NASDAQ: ENDP) from “hold” to “sell.” The target price for Endo Health Solutions is set to $30. Endo Health's shares closed at $35.96 yesterday.

Analysts at Morgan Stanley downgraded First Horizon National (NYSE: FHN) from “overweight” to “neutral.” The target price for First Horizon National is set to $11. First Horizon National's shares closed at $11.25 yesterday.

Analysts at Piper Jaffray downgraded Vera Bradley (NASDAQ: VRA) from “overweight” to “neutral.” The price target for Vera Bradley has been lowered from $32 to $24. Vera Bradley's shares closed at $22.46 yesterday.

Berenberg downgraded Oracle (NASDAQ: ORCL) from “buy” to “sell.” The target price for Oracle has been lowered from $35 to $28. Oracle's shares closed at $34.12 yesterday.

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Most Popular

Related Articles (ENDP + FHN)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free